Aptose Biosciences (TSX:APS) Other Stockholders Equity : C$0.00 Mil (As of Sep. 2024)

View and export this data going back to 1993. Start your Free Trial

What is Aptose Biosciences Other Stockholders Equity?

Aptose Biosciences's Other Stockholders Equity for the quarter that ended in Sep. 2024 was C$0.00 Mil.

Aptose Biosciences's quarterly Other Stockholders Equity declined from Mar. 2024 (C$0.00 Mil) to Jun. 2024 (C$-0.00 Mil) but then increased from Jun. 2024 (C$-0.00 Mil) to Sep. 2024 (C$0.00 Mil).

Aptose Biosciences's annual Other Stockholders Equity declined from Dec. 2021 (C$-0.00 Mil) to Dec. 2022 (C$-0.00 Mil) but then increased from Dec. 2022 (C$-0.00 Mil) to Dec. 2023 (C$-0.00 Mil).

Aptose Biosciences Other Stockholders Equity Historical Data

The historical data trend for Aptose Biosciences's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptose Biosciences Other Stockholders Equity Chart

Aptose Biosciences Annual Data

Trend

May14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

Aptose Biosciences Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															-	-	-	-	-

Aptose Biosciences Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Aptose Biosciences Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Aptose Biosciences's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Aptose Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptose Biosciences Inc (TSX:APS) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

APTO:USA LTI0:Germany LTI0:Germany

Address

251 Consumers Road, Suite 1105, Toronto, ON, CAN, M2J 4R3

Website

https://www.aptose.com

Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.

Executives

Bernd Robert Seizinger	Director
William Glenn Rice	Director, Senior Officer
Erich Platzer	Director
Rafael Bejar	Senior Officer
Warren Whitehead	Director
Gregory Kwok Lee Chow	Senior Officer
Jotin Marango	Senior Officer

Aptose Biosciences Headlines

No Headlines